Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

241
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
241
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

2.3K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
2.3K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

276
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
276
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

295
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
295
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

239
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of mortality in the elderly with different degree of sensorineural hearing loss in Taiwan.

Frontiers in neurology·2025
Same author

Hypothetical criteria and types for cochlear migraine.

Medicine·2025
Same author

Dose and Time Effects of Renin-Angiotensin Inhibitors on Patients With Advanced Stages 4 to 5 of Diabetic Kidney Disease.

Journal of the Endocrine Society·2024
Same author

Plasma Glial Cell-Derived Neurotrophic Factor and Insulin-like Growth Factor-1 Levels Were Not Correlated with the Severity of Age-Related Hearing Impairment in Humans.

ACS omega·2024
Same author

Association between Otosclerosis and Rubella in Taiwan: A Nationwide Case-Control Study.

Journal of clinical medicine·2023
Same author

Transurethral Incision of the Bladder Neck with or without Additional Procedure Resumes Spontaneous Voiding in Female Voiding Dysfunction-A Long-Term Retrospective Follow-Up.

Journal of clinical medicine·2023

Related Experiment Video

Updated: Oct 14, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.0K

Surgical treatments for obstructive sleep apnea decrease the risk of erectile dysfunction: A nationwide cohort study.

Juen-Haur Hwang1,2,3, Hueih-Ling Ong2,4, Yi-Chun Chen2,5

  • 1Department of Otolaryngology-Head and Neck Surgery, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.

Andrology
|November 8, 2021
PubMed
Summary

Surgical treatments for obstructive sleep apnea (OSA) may reduce the risk of erectile dysfunction (ED). This study found a 21% lower risk of ED in OSA patients who underwent surgery compared to those who did not.

Keywords:
cohort studyerectile dysfunctionobstructive sleep apneapropensity scoresurgical treatment

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

986
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

323

Related Experiment Videos

Last Updated: Oct 14, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.0K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

986
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

323

Area of Science:

  • Urology
  • Sleep Medicine
  • Public Health

Background:

  • Obstructive sleep apnea (OSA) is linked to a higher risk of erectile dysfunction (ED).
  • Limited evidence exists on the effect of OSA surgical treatments on ED risk.

Purpose of the Study:

  • To evaluate the impact of surgical interventions for OSA on the subsequent risk of developing ED.
  • Utilizing claims data from Taiwan's National Health Insurance Research Database (1997-2012).

Main Methods:

  • Analysis of 20,675 male adults diagnosed with OSA.
  • Comparison between a surgical treatment cohort (16,040 patients) and an untreated cohort (4,635 patients).
  • Propensity score matching (3:1) was used, analyzing 8,337 treated patients and 2,779 untreated controls.

Main Results:

  • Over 64,916 person-years, 396 (3.6%) patients developed ED.
  • Incidence rates of ED were 55.8 per 1000 person-years (treated) vs. 76.1 per 1000 person-years (untreated).
  • Surgical treatment for OSA was associated with a reduced risk of ED (adjusted HR, 0.79; 95% CI, 0.64-0.98).

Conclusions:

  • Surgical treatment for OSA is associated with a significant 21% reduction in the risk of developing ED.
  • This risk reduction was particularly notable in OSA patients without comorbidities like hypertension, diabetes, or obesity.